AMS:CRBN - Euronext Amsterdam - NL0010583399 - Common Stock - Currency: EUR
AMS:CRBN (3/7/2025, 7:00:00 PM)
20.18
-0.04 (-0.2%)
The current stock price of CRBN.AS is 20.18 EUR. In the past month the price decreased by -8.85%. In the past year, price increased by 0.5%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
6D81.DE | DUPONT DE NEMOURS INC | 19.09 | 29.92B | ||
DSFIR.AS | DSM-FIRMENICH AG | 10.51 | 25.51B | ||
BRG.OL | BORREGAARD ASA | 21.84 | 18.00B | ||
ELK.OL | ELKEM ASA | 29.74 | 14.84B | ||
SY1.DE | SYMRISE AG | 34.09 | 13.39B | ||
1COV.DE | COVESTRO AG | N/A | 11.08B | ||
AKZA.AS | AKZO NOBEL N.V. | 15.78 | 10.49B | ||
EVK.DE | EVONIK INDUSTRIES AG | 27.39 | 10.08B | ||
AMC.DE | ALBEMARLE CORP | N/A | 8.33B | ||
SYENS.BR | SYENSQO SA | N/A | 7.47B | ||
AKE.PA | ARKEMA | 10.06 | 6.30B | ||
WCH.DE | WACKER CHEMIE AG | 30.92 | 4.02B |
Corbion NV engages in the development, production, sale, and distribution of ingredients for food and biochemicals. The company is headquartered in Amsterdam, Noord-Holland and currently employs 2,431 full-time employees. The company operates through two segments: Biobased Ingredients and Biobased Innovations. The Biobased Ingredients segment comprises the Food business division and the Biochemicals business division. The Food business division develops preservation ingredients and microbial spoilage prevention products for the baking, meat, dairy, confectionery and beverage industries, and the Biochemicals business division produces bio-based chemicals derived from renewable resources such as sugar or starch. The Biobased Innovations segment creates new biotechnology business platforms, such aspoly lactic acid (PLA). The firm operates production sites in the United States, Brazil, Spain, the Netherlands and Thailand, and markets its products through a global network of retail offices.
CORBION NV
Piet Heinkade 127
Amsterdam NOORD-HOLLAND NL
Employees: 2727
Company Website: http://www.corbion.com/
Investor Relations: http://www.corbion.com/investor-relations
Phone: 31205906911
The current stock price of CRBN.AS is 20.18 EUR. The price decreased by -0.2% in the last trading session.
The exchange symbol of CORBION NV is CRBN and it is listed on the Euronext Amsterdam exchange.
CRBN.AS stock is listed on the Euronext Amsterdam exchange.
13 analysts have analysed CRBN.AS and the average price target is 27.69 EUR. This implies a price increase of 37.19% is expected in the next year compared to the current price of 20.18. Check the CORBION NV stock analysts ratings, price target forecast and up-and down grades for more detailed information.
CORBION NV (CRBN.AS) has a market capitalization of 1.18B EUR. This makes CRBN.AS a Small Cap stock.
CORBION NV (CRBN.AS) currently has 2727 employees.
CORBION NV (CRBN.AS) has a resistance level at 21.49. Check the full technical report for a detailed analysis of CRBN.AS support and resistance levels.
The Revenue of CORBION NV (CRBN.AS) is expected to grow by 5.18% in the next year. Check the estimates tab for more information on the CRBN.AS EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
CORBION NV (CRBN.AS) has a dividend yield of 3.02%. The yearly dividend amount is currently 0.56. Check the full fundamental report for a detailed analysis of CRBN.AS dividend history, reliability and sustainability.
CORBION NV (CRBN.AS) will report earnings on 2025-07-31.
The PE ratio for CORBION NV (CRBN.AS) is 6.19. This is based on the reported non-GAAP earnings per share of 3.26 and the current share price of 20.18 EUR. Check the full fundamental report for a full analysis of the valuation metrics for CRBN.AS.
ChartMill assigns a fundamental rating of 5 / 10 to CRBN.AS. While CRBN.AS belongs to the best of the industry regarding profitability, there are concerns on its financial health.
Over the last trailing twelve months CRBN.AS reported a non-GAAP Earnings per Share(EPS) of 3.26. The EPS increased by 167.14% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 14.92% | ||
ROA | 12.43% | ||
ROE | 24.88% | ||
Debt/Equity | 0.4 |
ChartMill assigns a Buy % Consensus number of 78% to CRBN.AS. The Buy consensus is the average rating of analysts ratings from 13 analysts.
For the next year, analysts expect an EPS growth of 54.84% and a revenue growth 5.18% for CRBN.AS